Internal Medicine · Rego Park, NY
NPI
1467490896
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9932 66th Rd Ste Lp
Rego Park, NY, 11374
Phone (718) 275-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
3,217 services
Medicare patients, 2024
293
Average age 76
Drug cost, 2024
$5.8M
22,271 prescriptions
Company payments, 2025
$2,279
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Semyon Kostko was code 99213 (office e&m - established), 847 times for 251 patients. In total Semyon Kostko billed 3,217 services in 32 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 847 | 251 | $72.35 | $61K |
| 99442 Telephone Services | Office | 421 | 221 | $66.54 | $28K |
| 36415 Venipuncture Blood Collection | Office | 414 | 228 | $4.98 | $2,063 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 195 | 195 | $20.45 | $3,988 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 187 | 187 | $129.58 | $24K |
| 99483 Office/Outpatient Services | Office | 168 | 165 | $218.46 | $37K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 165 | 165 | $26.86 | $4,431 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 127 | 127 | $20.57 | $2,612 |
| 93000 Electrocardiogram | Office | 112 | 107 | $10.76 | $1,205 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 107 | 102 | $26.86 | $2,874 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 94 | 30 | $1.03 | $97 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 88 | 27 | $0.46 | $40.87 |
| 96366 Intravenous Infusion, Hydration | Office | 87 | 27 | $16.82 | $1,463 |
| 96365 Intravenous Infusion, Hydration | Office | 86 | 27 | $55.05 | $4,734 |
| 99214 Office E&M - Established | Office | 28 | 27 | $94.03 | $2,633 |
By year: 2022 $227K for 3,747 services; 2023 $216K for 3,506 services; 2024 $182K for 3,217 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 414 | 228 | $4.98 | $2,063 |
Medicare prescription drug claims, 2024
In 2024, the drug Semyon Kostko prescribed most often to Medicare patients was Diclofenac Sodium, with 1,391 prescriptions and refills. In total Semyon Kostko wrote 22,271 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 1,391 | 1,439 | 191 | $1.1M |
| Amlodipine Besylate Generic | 923 | 1,015 | 134 | $2,679 |
| Linzess Linaclotide | 900 | 923 | 114 | $469K |
| Atorvastatin Calcium Generic | 806 | 963 | 129 | $2,950 |
| Rosuvastatin Calcium Generic | 576 | 660 | 89 | $2,838 |
| Metoprolol Succinate Generic | 544 | 611 | 69 | $3,684 |
| Donepezil Hcl Generic | 517 | 555 | 85 | $2,114 |
| Losartan Potassium Generic | 486 | 566 | 71 | $1,852 |
| Tamsulosin Hcl Generic | 480 | 567 | 72 | $3,106 |
| Dexilant Dexlansoprazole | 453 | 459 | 57 | $134K |
| Creon Lipase/Protease/Amylase | 443 | 487 | 69 | $556K |
| Omeprazole Generic | 437 | 463 | 70 | $1,882 |
| Metformin Hcl Generic | 436 | 496 | 63 | $23K |
| Vascepa Icosapent Ethyl | 419 | 435 | 61 | $146K |
| Zenpep Lipase/Protease/Amylase | 414 | 426 | 48 | $717K |
Brand drugs: 6,655 claims; generic drugs: 15,235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Semyon Kostko $2,279 ($2,279 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $362.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 7 | $362 |
| Amgen Inc. AMGN | 8 | $352 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $256 |
| Ardelyx, Inc. ARDX | 6 | $225 |
| Novo Nordisk Inc NVO | 2 | $208 |
| Aimmune Therapeutics, Inc. | 6 | $154 |
| Corcept Therapeutics CORT | 2 | $153 |
| Genzyme Corporation SNY | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $125 |
| Axsome Therapeutics, Inc. AXSM | 2 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.